Brain injury markers to predict thinking problems after sepsis
Part of Brain & nervous system, Infections, Mental health clinical trials.
This study looks at whether certain proteins in the blood can help predict if people who survive sepsis will have long-term thinking or memory issues. It aims to identify those at higher risk early so they can get the right support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are currently in an intensive care unit (ICU) for sepsis or septic shock.
- You have been in the ICU for less than 24 hours.
- You are on a breathing machine (ventilator) or receiving medicines to support your blood pressure (vasopressors).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how sepsis (a severe infection) affects brain wave patterns and thinking abilities. It aims to understand if different types of inflammation in sepsis are linked to different cognitive problems.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial checks if certain blood markers (CRP, CRP/albumin ratio, and neutrophil/lymphocyte ratio) can predict how well sepsis patients with normal blood pressure will do. It aims to help doctors better manage infections and survival.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
This study looks at markers of inflammation, infection, and immunity in patients who are in the critical care area. It aims to find early signs of how severe the illness might become, how well treatments work, and if infections will develop.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.